Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Groklaw
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: GroklawHow the Trial Will Go, Beginning Tomorrow (SCO v. Novell)
By Pamela Jones et al.
- Novell's opening statement
- SCO's opening statement
- Novell's affirmative witnesses
- SCO's affirmative witnesses
- Novell's rebuttal witnesses, if any
- SCO's sur-rebuttal witnesses, if any
- SCO's closing statement
- Novell's closing statement
They've also exchanged lists of witnesses they will call and in what order, and they agree that if there are to be any changes, they'll each make an effort "in good faith" to notify each other with at least 24 hours' notice, if possible.
I know what you're thinking. SCO. Good Faith. Hardy Har. But Novell got SCO to agree that this stipulation isn't a green light to suddenly add surprise witnesses. If SCO tries anything like that, the stipulation can be pointed to, and SCO will need to present a very good reason. Still, I wouldn't be amazed if there were a surprise or two here or there which SCO will say it couldn't help. They have a history of loving surprises.
To me, the biggest surprise is that so far as we know, SCO isn't calling any witnesses, like Microsoft or Sun, to tell the court what its SCOsource license was for. SCO needs somebody to say it was for UnixWare. That's a huge and stunning blank.
Full post as published by Groklaw on April 28, 2008 (boomark / email).
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...









